Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Genenta Science S.p.A. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 11 | 9 | −2 |
| Shares | 1.04M | 720.7K | −314.7K (−30.4%) |
| Value | $695.7K | $1.33M | +$630.5K (+90.6%) |
New holders (2)
Institutions that held Genenta Science S.p.A. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 36,913 | $68.0K | 0.00% |
| Ground Swell Capital, LLC | 14,374 | $26.4K | 0.03% |
Sold out (4)
Institutions that held Genenta Science S.p.A. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| AlTi Global, Inc. | 200,288 | $134.6K |
| Independent Advisor Alliance | 37,036 | $24.9K |
| XTX Topco Ltd | 24,527 | $16.5K |
| Morgan Stanley | 15,420 | $10.4K |